Session 10.4 Pharmacokinetics 2 Flashcards
what is bioavailability
the fraction of a defined dose which reaches its way into a specific body compartment - usually CVS/circulation
through IV = 100% as no physical/metabolic barriers to overcome… so used as a reference/comparison for other routes
how is oral bio availability measured
measure the 2 graphs (plasma conc v time):
total area under curve = IV route
total area under curve = oral route
F (0 no drug through-1)= amount reaching systemic circulation via oral route/total given by IV
what is bioavailability do
informs choice of administration route by how much enters systemic circulation
what is the first stage of drug distribution
bulk flow - from heart via arteries to capillaries
diffusion - capillaries to interstitial fluid to cell membranes to targets
BUT there may be barriers to diffusion such as other interactions and non target binding
what does drug distribution look at
where it could reach and interact with both therapeutic and non therapeutic targets as well as other molecules such as proteins and lipids
how does diffusion across capillaries affect drug distribution
different capillary types - continuous, fenestrated, sinusoid - variation in entry increases for lipophilic molecules, could aid drug entry to interstitital fluid or unaid it. one way it could aid is the capillary membrane has OAT and OCT
a drug can be
hydrophilic - carries net charge at physiological pH…dependent on transport mechanisms
or lipophilic - easily pass
what are the factors affecting drug distribution
drug molecule capillary permeability drug pKa and local pH presence of OAT/OCT - in capillary or traget tissue membrane interaction with proteins
what proteins do drugs bind to
albumen - globulins
lipoproteins - acid glycoproteins
how do drugs binding to protein affect drug distribution
only free drug molecules can bind to target sites, so if bound to protein by weak electrostatic forces eg:HSA with multiple binding sites- unable to bind so less free drug available for binding
these plasma/tissue ptoein bound drugs acts as dynamic resevoir
there are varying number of binding sites for given drug, some drugs want to bind to same site on same albumen…competition which affects free plasma cnc and pharmacodynamics
drug molecules
are solutes in body fluid compartments
plasma water
plasma water … 3l/3.5
extracellular water
plasma water and intersitital water … 14l
total body water
plasma water, intersitital water, intracellular water…42l
drugs move from
plasma -> intersitital -> intracellular
increasing penetration by drug into interstitial and intracellular fluid compartments
decreased plasma drug concentration
increased Vd
some drugs
easily enter intracellular
or stay in plasma
what barrier is found between plasma and interstitial and what is present there
capillary membrane barrier which has carrier OAT and OCT
what barrier is found between interstitial and intracellular and what is present there
carrier OCT/OAT - if not lipophilic need to get into intracellular space to enter target tissue
or drug targets if lipophilic
what is volume of distribution (Vd)
modelled that all compartments are one compartment and says drug distributes throughout body at time 0 which it doesnt, it takes time = PRETEND
referenced to plasma concentration
dependent on factors that affect transport across barrier, if aid = larger volume of distribution
smaller Vd value
less penetration of interstitial/intracellular fluid compartments
how is Vd measured
drug dose/plasma concentration of drug at time of 0
if lots of litres = high penetration
if units in litres = assume 70kg body
id units in litres/kg = to patients body weight
Vd can be affected by
lots of clinical conditions - pregancy, marked changes in body weight, renal failure, cancer, anaesthetic etc
how is Vd affected by high BMI
given lipopholic drug - distribute across all adipose tissue, so more drug required to reach brain
how is Vd affected by low BMI
lipophilic drugs not taken up by other compartments so must give a lower dose of drug
how does renal failure affect Vd
drug circulating may be removed slowly so hang around in body longer
how does being younger affect Vd
as child - 75% body water
expression of OAT and OCT different as well as phase 1 and 2 enzymes